Results for "Dasatinib Quercetin"

20 articles

Senolytics, Gene Therapy and Lifestyle Can Slow Cardiovascular Aging
Heart Health

Senolytics, Gene Therapy and Lifestyle Can Slow Cardiovascular Aging

A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.

Research Paper
May 11, 2026 0
Inside the Lab Methods Scientists Use to Test Senolytic Drugs
Longevity & Aging

Inside the Lab Methods Scientists Use to Test Senolytic Drugs

A comprehensive review of in vitro assays for inducing cellular senescence and screening senolytic drugs, highlighting key challenges in clinical translation.

Research Paper
May 10, 2026 0
Three Different Drugs Each Reverse Oxygen-Induced Lung Aging in Premature Infant Cells
Longevity & Aging

Three Different Drugs Each Reverse Oxygen-Induced Lung Aging in Premature Infant Cells

Fucoidan, dasatinib+quercetin, and MitoQ each counteract hyperoxia-driven cellular senescence in fetal airway cells via distinct mechanisms.

Research Paper
May 10, 2026 0
Chemotherapy Destroys Bones by Triggering Senescence in Marrow Fat Cells
Longevity & Aging

Chemotherapy Destroys Bones by Triggering Senescence in Marrow Fat Cells

A new study pinpoints chemotherapy-induced senescent bone marrow cells as the culprit behind bone loss, and shows senolytics can prevent it.

Research Paper
May 9, 2026 0
First Senolytic Trial in Alzheimer's Patients Reveals Promising Biomarker Shifts
Longevity & Aging

First Senolytic Trial in Alzheimer's Patients Reveals Promising Biomarker Shifts

A phase 1 trial of dasatinib + quercetin in 5 early AD patients uncovers fluid biomarker changes that could guide future senolytic trials.

Research Paper
May 7, 2026 0
Dasatinib and Quercetin Reverse Retinal Aging in Dry AMD Mouse Model
Longevity & Aging

Dasatinib and Quercetin Reverse Retinal Aging in Dry AMD Mouse Model

4-month senolytic treatment with D+Q cleared senescent RPE cells, reduced lipofuscin, and preserved vision in a preclinical dry AMD model.

Research Paper
May 7, 2026 0
Senolytics Fail to Protect Bone From Chemotherapy-Induced Loss
Cancer Research

Senolytics Fail to Protect Bone From Chemotherapy-Induced Loss

A mouse study finds that senolytic drugs cannot prevent chemotherapy-driven bone loss, challenging a leading hypothesis about its cause.

Research Paper
May 7, 2026 0
Senolytic Drug Combo Dasatinib and Quercetin Accelerates Rotator Cuff Healing in Aged Rats
Regenerative Medicine

Senolytic Drug Combo Dasatinib and Quercetin Accelerates Rotator Cuff Healing in Aged Rats

A senolytic pairing of dasatinib and quercetin cleared senescent cells at the tendon-bone junction, dramatically improving repair strength in aged rats.

Research Paper
May 7, 2026 0
Senolytics and Epalrestat Show Promise for Slowing Polycystic Kidney Disease
Autoimmune & Arthritis

Senolytics and Epalrestat Show Promise for Slowing Polycystic Kidney Disease

Senescent cells drive cyst growth in ADPKD, and targeting them with senolytics or the aldose reductase inhibitor epalrestat delays disease progression.

Research Paper
May 6, 2026 0
Smart Hydrogel Plus Senolytics and Exosomes Reverses Disc Degeneration in Animal Models
Regenerative Medicine

Smart Hydrogel Plus Senolytics and Exosomes Reverses Disc Degeneration in Animal Models

A novel anti-swelling hydrogel loaded with dasatinib, quercetin, and nucleus pulposus exosomes clears senescent cells and restores disc integrity in rats and goats.

Research Paper
May 6, 2026 0
Senolytic Drug Combo Slows Age-Related Hearing Loss in Mice
Longevity & Aging

Senolytic Drug Combo Slows Age-Related Hearing Loss in Mice

Dasatinib and quercetin clear senescent cochlear cells, reducing inflammation and preserving hair cells in aging mice.

Research Paper
May 6, 2026 0
Five Drug Classes Show Promise for Extending Human Healthspan and Reversing Aging
Longevity & Aging

Five Drug Classes Show Promise for Extending Human Healthspan and Reversing Aging

Comprehensive review identifies senolytics, NAD+ precursors, mTOR inhibitors and other compounds targeting aging hallmarks.

Research Paper
May 3, 2026 0
Senolytic Drug Combo Reverses Age-Related Bone Loss in Mice
Longevity & Aging

Senolytic Drug Combo Reverses Age-Related Bone Loss in Mice

Dasatinib plus quercetin cleared senescent cells and reduced inflammation, improving alveolar bone health in aged mice.

Research Paper
Apr 25, 2026 0
Cancer Drugs Repurposed as Senolytic Therapies Show Promise for Aging
Longevity & Aging

Cancer Drugs Repurposed as Senolytic Therapies Show Promise for Aging

Review reveals how anti-cancer drugs are being repurposed to eliminate senescent cells, opening new pathways for longevity treatments.

Research Paper
Apr 10, 2026 0
Bone-Targeted Liposomes Deliver Senolytics to Reverse Osteoporosis
Longevity & Aging

Bone-Targeted Liposomes Deliver Senolytics to Reverse Osteoporosis

Alendronate-modified liposomes carrying dasatinib and quercetin doubled bone volume in chemotherapy-induced osteoporosis models.

Research Paper
Apr 9, 2026 0
Senescent Liver Cells Drive Cancer Spread Through Toxic Extracellular Vesicles
Longevity & Aging

Senescent Liver Cells Drive Cancer Spread Through Toxic Extracellular Vesicles

New research reveals how aging liver cells release harmful vesicles that promote cancer metastasis across multiple tumor types.

Research Paper
Apr 7, 2026 0
New Test Predicts Which Senolytic Drugs Will Work for Individual Patients
Longevity & Aging

New Test Predicts Which Senolytic Drugs Will Work for Individual Patients

Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.

Research Paper
Apr 4, 2026 0
Nano-Encapsulated Senolytic Cocktail Reverses Egg Cell Aging in Female Mice
Longevity & Aging

Nano-Encapsulated Senolytic Cocktail Reverses Egg Cell Aging in Female Mice

Dasatinib and quercetin nanoparticles improve egg quality and fertility in aging mouse ovaries by clearing senescent cells.

Research Paper
Apr 2, 2026 0
Senolytic Drugs Show Promise and Peril for Heart Disease Treatment
Longevity & Aging

Senolytic Drugs Show Promise and Peril for Heart Disease Treatment

New review reveals senolytic therapies can both help and harm cardiovascular health, challenging clinical translation.

Research Paper
Mar 31, 2026 0
Senolytic Drugs Dasatinib and Quercetin Protect Against Gum Disease and Bone Loss
Longevity & Aging

Senolytic Drugs Dasatinib and Quercetin Protect Against Gum Disease and Bone Loss

Study shows senolytic combination therapy reduces cellular aging in gums and prevents periodontal bone loss in aging mice.

Research Paper
Mar 31, 2026 0
Page 1 of 2Next